zepbound and semaglutide vs. vs. Wegovy: What's the Difference? Zepbound Beats Wegovy in the

Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial

It is appropriate for adults with a BMI of 30 or higher, or 27 and above,particularly those who also experience weight-related health conditions like high blood pressure or type 2 diabetes.Most people begin to notice results within the first few weeks of treatment, with significant weight loss often occurring within two to three months

When gastric emptying is slowed by GLP-1 medications, this gastric distension lasts longer , leading to pressure, bloating, and prolonged fullness

But like all GLP-1 medications, it comes with potential side effects worth understanding before you start